Neuronal function and dysfunction of CYFIP2

from actin dynamics to early infantile epileptic encephalopathy

Yinhua Zhang, Yeunkum Lee, Kihoon Han

Research output: Contribution to journalComment/debate

Abstract

The cytoplasmic FMR1-interacting protein family (CYFIP1 and CYFIP2) are evolutionarily conserved proteins originally identified as binding partners of the fragile X mental retardation protein (FMRP), a messenger RNA (mRNA)-binding protein whose loss causes the fragile X syndrome. Moreover, CYFIP is a key component of the heteropentameric WAVE regulatory complex (WRC), a critical regulator of neuronal actin dynamics. Therefore, CYFIP may play key roles in regulating both mRNA translation and actin polymerization, which are critically involved in proper neuronal development and function. Nevertheless, compared to CYFIP1, neuronal function and dysfunction of CYFIP2 remain largely unknown, possibly due to the relatively less well established association between CYFIP2 and brain disorders. Despite high amino acid sequence homology between CYFIP1 and CYFIP2, several in vitro and animal model studies have suggested that CYFIP2 has some unique neuronal functions distinct from those of CYFIP1. Furthermore, recent whole-exome sequencing studies identified de novo hot spot variants of CYFIP2 in patients with early infantile epileptic encephalopathy (EIEE), clearly implicating CYFIP2 dysfunction in neurological disorders. In this review, we highlight these recent investigations into the neuronal function and dysfunction of CYFIP2, and also discuss several key questions remaining about this intriguing neuronal protein. [BMB Reports 2019; 52(5): 304-311].

Original languageEnglish
Pages (from-to)304-311
Number of pages8
JournalBMB reports
Volume52
Issue number5
DOIs
Publication statusPublished - 2019 May 1

Fingerprint

Brain Diseases
Actins
Fragile X Mental Retardation Protein
Exome
Fragile X Syndrome
Amino Acid Sequence Homology
Messenger RNA
Proteins
RNA-Binding Proteins
Nervous System Diseases
Polymerization
Animal Models
Brain
Animals
Association reactions
Amino Acids

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Neuronal function and dysfunction of CYFIP2 : from actin dynamics to early infantile epileptic encephalopathy. / Zhang, Yinhua; Lee, Yeunkum; Han, Kihoon.

In: BMB reports, Vol. 52, No. 5, 01.05.2019, p. 304-311.

Research output: Contribution to journalComment/debate

@article{cf38d38d048c4a4cafc6291f2c6bca20,
title = "Neuronal function and dysfunction of CYFIP2: from actin dynamics to early infantile epileptic encephalopathy",
abstract = "The cytoplasmic FMR1-interacting protein family (CYFIP1 and CYFIP2) are evolutionarily conserved proteins originally identified as binding partners of the fragile X mental retardation protein (FMRP), a messenger RNA (mRNA)-binding protein whose loss causes the fragile X syndrome. Moreover, CYFIP is a key component of the heteropentameric WAVE regulatory complex (WRC), a critical regulator of neuronal actin dynamics. Therefore, CYFIP may play key roles in regulating both mRNA translation and actin polymerization, which are critically involved in proper neuronal development and function. Nevertheless, compared to CYFIP1, neuronal function and dysfunction of CYFIP2 remain largely unknown, possibly due to the relatively less well established association between CYFIP2 and brain disorders. Despite high amino acid sequence homology between CYFIP1 and CYFIP2, several in vitro and animal model studies have suggested that CYFIP2 has some unique neuronal functions distinct from those of CYFIP1. Furthermore, recent whole-exome sequencing studies identified de novo hot spot variants of CYFIP2 in patients with early infantile epileptic encephalopathy (EIEE), clearly implicating CYFIP2 dysfunction in neurological disorders. In this review, we highlight these recent investigations into the neuronal function and dysfunction of CYFIP2, and also discuss several key questions remaining about this intriguing neuronal protein. [BMB Reports 2019; 52(5): 304-311].",
author = "Yinhua Zhang and Yeunkum Lee and Kihoon Han",
year = "2019",
month = "5",
day = "1",
doi = "10.5483/bmbrep.2019.52.5.097",
language = "English",
volume = "52",
pages = "304--311",
journal = "BMB Reports",
issn = "1976-6696",
publisher = "The Biochemical Society of the Republic of Korea",
number = "5",

}

TY - JOUR

T1 - Neuronal function and dysfunction of CYFIP2

T2 - from actin dynamics to early infantile epileptic encephalopathy

AU - Zhang, Yinhua

AU - Lee, Yeunkum

AU - Han, Kihoon

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The cytoplasmic FMR1-interacting protein family (CYFIP1 and CYFIP2) are evolutionarily conserved proteins originally identified as binding partners of the fragile X mental retardation protein (FMRP), a messenger RNA (mRNA)-binding protein whose loss causes the fragile X syndrome. Moreover, CYFIP is a key component of the heteropentameric WAVE regulatory complex (WRC), a critical regulator of neuronal actin dynamics. Therefore, CYFIP may play key roles in regulating both mRNA translation and actin polymerization, which are critically involved in proper neuronal development and function. Nevertheless, compared to CYFIP1, neuronal function and dysfunction of CYFIP2 remain largely unknown, possibly due to the relatively less well established association between CYFIP2 and brain disorders. Despite high amino acid sequence homology between CYFIP1 and CYFIP2, several in vitro and animal model studies have suggested that CYFIP2 has some unique neuronal functions distinct from those of CYFIP1. Furthermore, recent whole-exome sequencing studies identified de novo hot spot variants of CYFIP2 in patients with early infantile epileptic encephalopathy (EIEE), clearly implicating CYFIP2 dysfunction in neurological disorders. In this review, we highlight these recent investigations into the neuronal function and dysfunction of CYFIP2, and also discuss several key questions remaining about this intriguing neuronal protein. [BMB Reports 2019; 52(5): 304-311].

AB - The cytoplasmic FMR1-interacting protein family (CYFIP1 and CYFIP2) are evolutionarily conserved proteins originally identified as binding partners of the fragile X mental retardation protein (FMRP), a messenger RNA (mRNA)-binding protein whose loss causes the fragile X syndrome. Moreover, CYFIP is a key component of the heteropentameric WAVE regulatory complex (WRC), a critical regulator of neuronal actin dynamics. Therefore, CYFIP may play key roles in regulating both mRNA translation and actin polymerization, which are critically involved in proper neuronal development and function. Nevertheless, compared to CYFIP1, neuronal function and dysfunction of CYFIP2 remain largely unknown, possibly due to the relatively less well established association between CYFIP2 and brain disorders. Despite high amino acid sequence homology between CYFIP1 and CYFIP2, several in vitro and animal model studies have suggested that CYFIP2 has some unique neuronal functions distinct from those of CYFIP1. Furthermore, recent whole-exome sequencing studies identified de novo hot spot variants of CYFIP2 in patients with early infantile epileptic encephalopathy (EIEE), clearly implicating CYFIP2 dysfunction in neurological disorders. In this review, we highlight these recent investigations into the neuronal function and dysfunction of CYFIP2, and also discuss several key questions remaining about this intriguing neuronal protein. [BMB Reports 2019; 52(5): 304-311].

UR - http://www.scopus.com/inward/record.url?scp=85066456026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066456026&partnerID=8YFLogxK

U2 - 10.5483/bmbrep.2019.52.5.097

DO - 10.5483/bmbrep.2019.52.5.097

M3 - Comment/debate

VL - 52

SP - 304

EP - 311

JO - BMB Reports

JF - BMB Reports

SN - 1976-6696

IS - 5

ER -